CytoGenix, USDA to develop vaccine against livestock disease

By Lisa Kerner

Erie, Pa., May 8 - CytoGenix, Inc. said it has entered into a formal Cooperative Research and Development Agreement with the USDA Agricultural Research Service to develop synDNA vaccines against existing and emerging strains of the bacteria that causes brucellosis, a cause of miscarriages in domestic sheep, goats, cattle, pigs and in wildlife such as deer, elk and bison.

According to a company news release, state and federal governments have spent $11 billion over the last 45 years in an attempt to eradicate this disease.

CytoGenix is a Houston-based biopharmaceutical company that develops and markets products and services based on its proprietary ssDNA expression technology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.